Identification of a Link between Suspected Metabolic Syndrome and Cognitive Impairment within Pharmaceutical Care in Adults over 75 Years of Age

The prevalence of metabolic syndrome (MetS) and cognitive impairment (CI) is increasing with age. MetS reduces overall cognition, and CI predicts an increased risk of drug-related problems. We investigated the impact of suspected MetS (sMetS) on cognition in an aging population receiving pharmaceuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Macekova, Zuzana, Fazekas, Tomas, Krivosova, Michaela, Dragasek, Jozef, Zufkova, Viera, Klimas, Jan, Snopkova, Miroslava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000537/
https://www.ncbi.nlm.nih.gov/pubmed/36900723
http://dx.doi.org/10.3390/healthcare11050718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000537/
https://www.ncbi.nlm.nih.gov/pubmed/36900723
http://dx.doi.org/10.3390/healthcare11050718

Ejemplares similares